Norcross-based SpectRx Inc. announced that  U.S. clinical trials will be held prior to submission to the Food and Drug Administration (FDA) of  BiliCheck, the first commercially available hand-held, non-invasive…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Phil Bolton is the founder and publisher emeritus of Global Atlanta.